GT Medical Technologies has obtained a $35 million venture loan facility to fund expansion of its technology to treat ...
GT Medical Technologies, maker of the GammaTile bioresorbable collagen tile, announced that it secured a $35 million venture ...
These room-sized medical devices would always cause some ... It was the third radiation therapy machine by the company, preceded by the Therac-6 and Therac-20. AECL built the Therac-6 and 20 ...
Zacks Small Cap Research on MSN23d
DRTS: Company Seeks to Develop Significant Advance in Cancer Therapy with Alpha DaRTAlpha DaRT more precise compared to traditional radiation therapy ... received FDA Breakthrough Device Designation in June ...
Scripps News on MSN10d
Hospitals begin offering breakthrough radiation therapy for metastatic cancer tumorsRadiation is part of treatment for about half of cancer patients. A breakthrough could change the future of the treatment.
Highlights include new safety and efficacy data of Barrigel™rectal spacer, the first and only sculptable rectal spacer1-3• Teleflex to host ...
GlobalData on MSN3d
FDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatmentSecondary efficacy objectives of the Alpha DaRT cancer therapy study will focus on progression-free survival, overall ...
(WYTV)- Radiation therapy is a common treatment for cancer, and now we’re seeing that it may also help treat dangerous heart rhythms. It goes by the name proton beam therapy, to treat patients with ...
Radiation is part of treatment ... called SCINTIX, from biotech company RefleXion. The FDA granted SCINTIX a Breakthrough Device designation in 2021, and in 2023 granted clearance to SCINTIX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback